Acticor Biotech
Since 2015, Veronia was involved in numerous clinical trials from phase I to phase IV, mainly in oncology (solid tumors and lymphoma as well) as CRA and then as Lead CRA. She works for numerous CROs such as Altizem, Aepodia, DOCS/ICON or Labcorp.
This person is not in any offices
Acticor Biotech
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.